782 filings
8-A12B
VNDA
Vanda Pharmaceuticals Inc
17 Apr 24
Registration of securities on exchange
5:26pm
8-K
VNDA
Vanda Pharmaceuticals Inc
17 Apr 24
Entry into a Material Definitive Agreement
5:19pm
8-K
VNDA
Vanda Pharmaceuticals Inc
3 Apr 24
Vanda Pharmaceuticals’ Fanapt® (iloperidone) Receives U.S. FDA Approval
4:32pm
8-K
VNDA
Vanda Pharmaceuticals Inc
7 Mar 24
Vanda Pharmaceuticals Announces FDA Update for supplemental NDA for HETLIOZ® in the Treatment of Insomnia
4:31pm
4
Timothy Williams
6 Mar 24
Vanda Pharmaceuticals / Timothy Williams ownership change
4:50pm
4
Joakim Wijkstrom
6 Mar 24
Vanda Pharmaceuticals / Joakim Wijkstrom ownership change
4:48pm
4
Mihael Hristos Polymeropoulos
6 Mar 24
Vanda Pharmaceuticals / Mihael Hristos Polymeropoulos ownership change
4:47pm
4
VNDA
Vanda Pharmaceuticals Inc
6 Mar 24
Vanda Pharmaceuticals / Kevin Patrick Moran ownership change
4:46pm
4
VNDA
Vanda Pharmaceuticals Inc
6 Mar 24
Vanda Pharmaceuticals / Gunther Birznieks ownership change
4:46pm
144
Timothy Williams
4 Mar 24
Notice of proposed sale of securities
9:14pm
144
VNDA
Vanda Pharmaceuticals Inc
4 Mar 24
Notice of proposed sale of securities
9:12pm
144
Mihael Hristos Polymeropoulos
4 Mar 24
Notice of proposed sale of securities
9:10pm
144
Kevin Patrick Moran
4 Mar 24
Notice of proposed sale of securities
9:08pm
144
Gunther Birznieks
4 Mar 24
Notice of proposed sale of securities
9:06pm
4
VNDA
Vanda Pharmaceuticals Inc
21 Feb 24
Vanda Pharmaceuticals / Timothy Williams ownership change
4:53pm
4
VNDA
Vanda Pharmaceuticals Inc
21 Feb 24
Vanda Pharmaceuticals / Joakim Wijkstrom ownership change
4:52pm
4
Kevin Patrick Moran
21 Feb 24
Vanda Pharmaceuticals / Kevin Patrick Moran ownership change
4:52pm
4
VNDA
Vanda Pharmaceuticals Inc
21 Feb 24
Vanda Pharmaceuticals / Mihael Hristos Polymeropoulos ownership change
4:52pm
4
Gunther Birznieks
21 Feb 24
Vanda Pharmaceuticals / Gunther Birznieks ownership change
4:50pm
8-K
VNDA
Vanda Pharmaceuticals Inc
21 Feb 24
Departure of Directors or Certain Officers
4:32pm